These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24059549)

  • 21. [Surfactant to premature neonates].
    Jacobsen T; Verder H
    Ugeskr Laeger; 1991 Jul; 153(31):2166-9. PubMed ID: 1866827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriate surfactant usage in 1996.
    Soll RF
    Eur J Pediatr; 1996 Aug; 155 Suppl 2():S8-13. PubMed ID: 8839739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?
    Sinha S; Moya F; Donn SM
    Curr Opin Pediatr; 2007 Apr; 19(2):150-4. PubMed ID: 17496757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of preterm infants receiving surfactant supplementation.
    Bevilacqua G; Gaioni L; Parmigiani S
    Eur Respir J Suppl; 1989 Mar; 3():87s-90s. PubMed ID: 2742686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European consensus guidelines on the management of neonatal respiratory distress syndrome.
    Sweet D; Bevilacqua G; Carnielli V; Greisen G; Plavka R; Saugstad OD; Simeoni U; Speer CP; Valls-I-Soler A; Halliday H; ;
    J Perinat Med; 2007; 35(3):175-86. PubMed ID: 17480144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant replacement therapy.
    Halliday HL
    Pediatr Pulmonol Suppl; 1995; 11():96-7. PubMed ID: 7547366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent clinical trials of surfactant treatment for neonates.
    Halliday HL
    Biol Neonate; 2006; 89(4):323-9. PubMed ID: 16770072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of surfactant replacement in preterm babies.
    Mugford M; Howard S
    Pharmacoeconomics; 1993 May; 3(5):362-73. PubMed ID: 10146887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant: current and potential therapeutic application in infants and adults.
    Lewis J; Veldhuizen RA
    J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of surfactants in 2009.
    Sweet DG; Halliday HL
    Arch Dis Child Educ Pract Ed; 2009 Jun; 94(3):78-83. PubMed ID: 19460896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
    Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
    Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human surfactant in the treatment of respiratory distress syndrome. A spectrum of clinical responses.
    Hallman M; Pohjavuori M; Järvenpää AL; Bry K; Merritt TA; Pesonen E
    Eur Respir J Suppl; 1989 Mar; 3():77S-80S. PubMed ID: 2663000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
    Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection.
    Vento G; Tana M; Tirone C; Aurilia C; Lio A; Perelli S; Ricci C; Romagnoli C
    Acta Biomed; 2012; 83 Suppl 1():33-6. PubMed ID: 23029875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.